Charterhouse completes acquisition of Animalcare Group
Charterhouse Capital Partners has completed the acquisition of Animalcare Group, following its delisting from the London Stock Exchange.
Charterhouse Capital Partners has finalized its acquisition of animal healthcare firm Animalcare Group, following the company's removal from the London Stock Exchange. Based in York, Animalcare Group specializes in producing and distributing products for pets, horses, and livestock. The company holds approximately 150 animal health pharmaceutical brands, with a focus on dental, equine, and pain management products, and operates in Europe and the Asia-Pacific region.
Animalcare Group asserts that the animal healthcare industry is a resilient and diversified market driven by factors such as growing pet ownership, heightened awareness among pet owners, increased treatment alternatives, and enhanced veterinary education. Charterhouse Capital Partners acknowledges that the company's unique product range, robust research and development pipeline, and successful track record in strategic acquisitions make Animalcare Group well-positioned for future expansion.
The investment, according to Charterhouse, aligns with their objective of collaborating with top-tier healthcare organizations that possess robust market positions and clear avenues for value generation. The firm intends to collaborate with Animalcare Group's CEO Jennifer Winter and the current management team to bolster the company's dedication to innovation, operational excellence, and strategic mergers and acquisitions.
Together, they aspire to expedite global growth, bolster the product portfolio, and stimulate long-term sustainable development.
Written by urgent.news from Private Equity Wire's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
